The Loss of ATRX Promotes Susceptibility to KRAS-Mediated Pancreatic Disease

被引：0
|
作者：
Young, C. [1 ]
Howlett, C. [2 ]
Pin, C. [1 ]
机构：
[1] Univ Western Ontario, Schulich Sch Med & Dent, Dept Physiol & Pharmacol, Childrens Hlth Res Inst, London, ON, Canada
[2] Univ Western Ontario, Schulich Sch Med & Dent, Dept Pathol & Lab Med, London, ON, Canada
来源：
PANCREAS | 2016年 / 45卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：1549 / 1549
页数：1
相关论文
共 50 条
  • [21] Deficient Rnf43 potentiates hyperactive Kras-mediated pancreatic preneoplasia initiation and malignant transformation
    Xian Zhou
    Zhichao Sun
    Mengdi Zhang
    Xiaoyu Qu
    Shuhui Yang
    Lianmei Wang
    Yanling Jing
    Li Li
    Weiwei Deng
    Fangming Liu
    Jin Di
    Jie Chen
    Jian Wu
    Hongbing Zhang
    Animal Models and Experimental Medicine, 2022, 5 (01) : 61 - 71
  • [22] Role of EGFR in KRAS-mediated resistances in colorectal cancer
    Adachi-Fernandez, Emi
    Moreno-Viedma, Veronica
    Krauss, Dana
    Kirchmair, Alexander
    Trajanoski, Zlatko
    Sibilia, Maria
    MOLECULAR CANCER RESEARCH, 2023, 21 (05)
  • [23] Exploiting KRAS-mediated metabolic reprogramming as a therapeutic target
    Bootsma, Sanne
    van Neerven, Sanne M.
    Vermeulen, Louis
    NATURE GENETICS, 2021, 53 (01) : 9 - 10
  • [24] Exploiting KRAS-mediated metabolic reprogramming as a therapeutic target
    Sanne Bootsma
    Sanne M. van Neerven
    Louis Vermeulen
    Nature Genetics, 2021, 53 : 9 - 10
  • [25] LIN28 is expressed in glioblastomas and promotes KRAS-mediated transformation of human neural stem cells
    Mao, Xinggang
    Raabe, Eric H.
    Maciaczyk, Jarek
    Kahlert, Ulf
    Nikkhah, Guido
    Eberhart, Charles G.
    CANCER RESEARCH, 2011, 71
  • [26] Mitochondrial metabolism and ROS generation are essential for Kras-mediated tumorigenicity
    Weinberg, Frank
    Hamanaka, Robert
    Wheaton, William W.
    Weinberg, Samuel
    Joseph, Joy
    Lopez, Marcos
    Kalyanaraman, Balaraman
    Mutlu, Goekhan M.
    Budinger, G. R. Scott
    Chandel, Navdeep S.
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2010, 107 (19) : 8788 - 8793
  • [27] Deficient Rnf43 potentiates hyperactive Kras-mediated pancreatic preneoplasia initiation and malignant transformation
    Zhou, Xian
    Sun, Zhichao
    Zhang, Mengdi
    Qu, Xiaoyu
    Yang, Shuhui
    Wang, Lianmei
    Jing, Yanling
    Li, Li
    Deng, Weiwei
    Liu, Fangming
    Di, Jin
    Chen, Jie
    Wu, Jian
    Zhang, Hongbing
    ANIMAL MODELS AND EXPERIMENTAL MEDICINE, 2022, 5 (01) : 61 - 71
  • [28] Localized Hypertrophic Neuropathy as a Neoplastic Manifestation of KRAS-Mediated RASopathy
    Vizcaino, M. Adelita
    Belzberg, Allan
    Ahlawat, Shivani
    Belakhoua, Sarra
    Chen, Liam
    Staedtke, Verena
    Rodriguez, Fausto J.
    JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2020, 79 (06): : 647 - 651
  • [29] Loss of ATRX Does Not Confer Susceptibility to Osteoarthritis
    Solomon, Lauren A.
    Russell, Bailey A.
    Makar, David
    Berube, Nathalie G.
    Beier, Frank
    PLOS ONE, 2013, 8 (12):
  • [30] ATRX Loss in Pancreatic Neuroendocrine Tumors Is Associated With Disease Recurrence and Decreased Survival
    Singhi, Aatur
    Lu, Ta-Chiang
    Ma, Changqing
    Cressman, Kristi
    Bahary, Nathan
    Zeh, Herbert
    Hogg, Melissa
    Zureikat, Amer
    LABORATORY INVESTIGATION, 2015, 95 : 449A - 449A
12345